DK0501378T3 - NMDA-antagonister - Google Patents

NMDA-antagonister

Info

Publication number
DK0501378T3
DK0501378T3 DK92103066.4T DK92103066T DK0501378T3 DK 0501378 T3 DK0501378 T3 DK 0501378T3 DK 92103066 T DK92103066 T DK 92103066T DK 0501378 T3 DK0501378 T3 DK 0501378T3
Authority
DK
Denmark
Prior art keywords
halo
formula
nmda antagonists
epilepsy
anxiety
Prior art date
Application number
DK92103066.4T
Other languages
English (en)
Inventor
Francesco G Salituro
Ian A Mcdonald
Michael G Palfreyman
Robert Schwarcz
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of DK0501378T3 publication Critical patent/DK0501378T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK92103066.4T 1991-02-28 1992-02-24 NMDA-antagonister DK0501378T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66267091A 1991-02-28 1991-02-28

Publications (1)

Publication Number Publication Date
DK0501378T3 true DK0501378T3 (da) 1995-03-20

Family

ID=24658685

Family Applications (2)

Application Number Title Priority Date Filing Date
DK92103066.4T DK0501378T3 (da) 1991-02-28 1992-02-24 NMDA-antagonister
DK94110261T DK0624569T3 (da) 1991-02-28 1992-02-24 MMDA-antagonister

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK94110261T DK0624569T3 (da) 1991-02-28 1992-02-24 MMDA-antagonister

Country Status (15)

Country Link
EP (2) EP0624569B1 (da)
JP (1) JP3168566B2 (da)
KR (2) KR100237264B1 (da)
AT (2) ATE168989T1 (da)
AU (2) AU643365B2 (da)
CA (1) CA2061836C (da)
DE (2) DE69201141T2 (da)
DK (2) DK0501378T3 (da)
ES (2) ES2122098T3 (da)
FI (1) FI920880A (da)
GR (1) GR3015130T3 (da)
HU (1) HU213214B (da)
IE (2) IE65728B1 (da)
NO (1) NO178727C (da)
NZ (1) NZ241718A (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69224069T2 (de) * 1991-09-09 1998-07-02 Warner-Lambert Co., Ann Arbor, Mich. Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält
US5318985A (en) * 1991-12-20 1994-06-07 Merrell Dow Pharmaceuticals Inc. Potentiation of NMDA antagonists
IT1265101B1 (it) * 1993-07-23 1996-10-30 Erba Carlo Spa Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
US5519055A (en) * 1993-08-06 1996-05-21 University Of Maryland At Baltimore Substituted kynurenines and process for their preparation
US5786508A (en) * 1994-07-15 1998-07-28 Pharmacia & Upjohn S.P.A. Substituted kynurenines and process for their preparation
GB9521486D0 (en) * 1995-10-20 1995-12-20 Pharmacia Spa Fluoro-substituted benzoylpropionic acid derivatives
SE9901237D0 (sv) * 1999-04-06 1999-04-06 Astra Ab Novel use
EP1964835A1 (en) * 2007-02-28 2008-09-03 Centre National de la Recherche Scientifique Derivatives of psammaplin A, a method for their synthesis and their use for the prevention or treatment of cancer
KR101308507B1 (ko) * 2011-07-07 2013-09-17 (주)비알뷰티플레볼루션 트립토판을 함유하는 여드름 치료제 및 피지분비 억제제, 및 이를 포함하는 광역학적 치료용 키트
US20180305298A1 (en) * 2015-10-16 2018-10-25 Auspex Pharmaceuticals, Inc. Deuterated chlorokynurenines for the treatment of neuropsychiatric disorders
EP3427729A1 (en) * 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions
CN118026866A (zh) 2018-02-09 2024-05-14 维斯塔津治疗公司 4-氯代犬尿氨酸及中间体的合成

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1179866B (it) * 1984-12-12 1987-09-16 Rotta Research Lab Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono
IT1206078B (it) * 1987-06-03 1989-04-14 Polifarma Spa Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico
IT1237472B (it) * 1989-10-04 1993-06-07 Polifarma Spa Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico.
DE19502075A1 (de) * 1995-01-24 1996-07-25 Grohe Armaturen Friedrich Auslaufarmatur mit Befestigungseinrichtung

Also Published As

Publication number Publication date
IE65728B1 (en) 1995-11-15
FI920880A0 (fi) 1992-02-27
ES2122098T3 (es) 1998-12-16
JPH0586027A (ja) 1993-04-06
CA2061836A1 (en) 1992-08-29
CA2061836C (en) 2006-05-02
HU9200658D0 (en) 1992-05-28
NO920784L (no) 1992-08-31
NO178727B (no) 1996-02-12
DE69201141T2 (de) 1995-05-11
KR100237264B1 (ko) 2000-02-01
NZ241718A (en) 1994-07-26
NO920784D0 (no) 1992-02-27
ATE116969T1 (de) 1995-01-15
DK0624569T3 (da) 1998-10-26
DE69201141D1 (de) 1995-02-23
IE920631A1 (en) 1992-09-09
EP0624569B1 (en) 1998-07-29
EP0501378A1 (en) 1992-09-02
AU4497593A (en) 1993-11-18
HU213214B (en) 1997-03-28
KR100261933B1 (ko) 2000-07-15
AU1114492A (en) 1992-09-03
EP0501378B1 (en) 1995-01-11
JP3168566B2 (ja) 2001-05-21
ATE168989T1 (de) 1998-08-15
HUT67033A (en) 1995-01-30
FI920880A (fi) 1992-08-29
DE69226447T2 (de) 1999-04-22
KR920016418A (ko) 1992-09-24
AU643365B2 (en) 1993-11-11
GR3015130T3 (en) 1995-05-31
IE80774B1 (en) 1999-02-10
NO178727C (no) 1996-05-22
AU656278B2 (en) 1995-01-27
EP0624569A1 (en) 1994-11-17
ES2069921T3 (es) 1995-05-16
DE69226447D1 (de) 1998-09-03

Similar Documents

Publication Publication Date Title
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
BRPI0409109A (pt) novos compostos
DE69010139D1 (de) Haarkräftigungsmittel.
ATE168989T1 (de) Nmda antagonisten
BR0208468A (pt) Camsilato de amlodipina e processo para sua preparação
ES2133324T3 (es) Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y metodos de uso.
CY1119257T1 (el) Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα δεξτρομεθορφανης n-meθυλ-d-ασπαρτικων (nmda)
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
EA200400806A1 (ru) Способ получения эхинокандиновых соединений
FI891582A0 (fi) Bicyklisk aminderivat och foerfarande foer dess framstaellning.
ES2082882T3 (es) Procedimiento para la fabricacion de derivados de acidos-3-amino-2-(het)aroil-acrilicos.
DK526087D0 (da) Antikonvulsive aminosyrederivater
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
ES2169723T3 (es) Derivados de piridinio y su uso para determinar trastornos del tejido conectivo en seres humanos y animales.
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
ES2062214T3 (es) Derivados de aminooligohidroxi inhibidores de renina.
ATE402178T1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza- benzoäcüfluoren-6-carbonsäurederivate als nmda- antagonisten
RU94017664A (ru) Соединения, используемые в качестве антагонистов 5-нт-рецепторов, способ получения, фармацевтическая композиция
GT199100061A (es) Derivados de acido acetico
DOP2001000245A (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso.
MY135855A (en) "pyrrolopyrimidinone derivatives, process of preparation and use"
SE9704835D0 (sv) New compound